Nordic Nanovector ASA (DE:8NN) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Thor Medical ASA is set to host a capital markets update on November 25, 2024, in Stockholm, where key discussions will focus on its innovative alpha-emitter production for cancer treatment and its strategic partnership with ARTBIO. This event marks an important milestone as the company moves towards establishing a commercial production plant, potentially boosting investor confidence. Attendees can join the event in person or via webcast.
For further insights into DE:8NN stock, check out TipRanks’ Stock Analysis page.
